PKM2’s SUMOylation promotes interaction with ARRDC1 and secretion via exosomes into the tumor microenvironment, activating STAT3 phosphorylation in monocytes and inducing their metabolic reprogramming and differentiation into macrophages (7). Here, ARRDC1 is linked to neoplasm.